Morrison Briggs
SEC CIK 1654430 · EDGAR
BoughtSold
Most active insiders at ARVN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Houston John G | Dir | — | $466.2K |
| 2 | Morrison Briggs | Dir | $268.0K | — |
| 3 | Berkowitz Noah | Chief Medical Off | — | $249.4K |
| 4 | Teel Randy | Pres, CEO, Dir | — | $226.5K |
| 5 | Saik Andrew | CFO | — | $218.2K |
| 6 | Cacace Angela M | CSO | — | $214.0K |
| 7 | Loomis David K | VP, CAO | — | $46.9K |
| 8 | Kennedy Edward Moore Jr. | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Bain Linda | Dir | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-26 16:22 | 2026-06-24 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | A - Grant | $0.00 | +15.5K | 111.5K | +16% | $0 |
| 2026-03-09 | 2026-03-06 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | P - Purchase | $13.40 | +20.0K | 96.0K | +26% | +$268.0K | |
| 2025-09-24 | 2025-09-22 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | P - Purchase | $7.57 | +30.0K | 76.0K | +65% | +$227.1K | |
| D | 2025-06-27 | 2025-06-25 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | A - Grant | $0.00 | +16.0K | 46.0K | +53% | $0 |
| D | 2024-05-31 | 2024-05-29 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | A - Grant | $0.00 | +5,899 | 30.0K | +24% | $0 |
| 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | A - Grant | $0.00 | +17.0K | 34.8K | +95% | $0 | |
| DT | 2023-08-10 | 2023-08-09 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | S - Sale+OE | $18.27 | -52.9K | 17.8K | -75% | -$965.7K |
| DT | 2023-08-10 | 2023-08-09 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | M - OptEx | $8.77 | +52.9K | 70.7K | +296% | +$463.5K |
| DT | 2023-07-11 | 2023-07-10 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | S - Sale+OE | $20.40 | -52.9K | 17.8K | -75% | -$1.08M |
| DT | 2023-07-11 | 2023-07-10 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | M - OptEx | $8.77 | +52.9K | 70.7K | +296% | +$463.5K |
| D | 2023-06-20 | 2023-06-15 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | A - Grant | $0.00 | +4,121 | 24.1K | +21% | $0 |
| DMT | 2023-06-09 | 2023-06-09 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | S - Sale+OE | $21.18 | -52.9K | 46.1K | -53% | -$1.12M |
| DMT | 2023-06-09 | 2023-06-09 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | M - OptEx | $7.66 | +52.9K | 70.7K | +296% | +$404.8K |
| DT | 2023-05-10 | 2023-05-09 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | M - OptEx | $6.38 | +52.9K | 70.7K | +296% | +$337.2K |
| DT | 2023-05-10 | 2023-05-09 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | S - Sale+OE | $21.41 | -52.9K | 17.8K | -75% | -$1.13M |
| DT | 2023-04-12 | 2023-04-10 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | M - OptEx | $6.38 | +52.9K | 70.7K | +296% | +$337.2K |
| DT | 2023-04-12 | 2023-04-10 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Dir | S - Sale+OE | $19.53 | -52.9K | 17.8K | -75% | -$1.03M |
| D | 2023-03-14 | 2023-03-13 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $22.53 | -52.9K | 17.8K | -75% | -$1.19M |
| D | 2023-03-14 | 2023-03-13 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $6.38 | +52.9K | 70.7K | +296% | +$337.2K |
| D | 2023-02-08 | 2023-02-06 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $6.38 | +52.9K | 70.7K | +296% | +$337.2K |
| D | 2023-02-08 | 2023-02-06 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $26.83 | -52.9K | 17.8K | -75% | -$1.42M |
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $23.11 | -174.0K | 17.8K | -91% | -$4.02M |
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $10.90 | +174.0K | 132.2K | New | +$1.90M |
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.90 | +279.4K | 84.6K | New | +$2.21M |
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $23.64 | -279.4K | 17.8K | -94% | -$6.60M |
| D | 2022-07-05 | 2022-07-01 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.20 | +62.3K | 80.1K | +349% | +$448.5K |
| D | 2022-07-05 | 2022-07-01 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $19.00 | -62.3K | 17.8K | -78% | -$1.18M |
| DM | 2022-04-18 | 2022-04-14 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | S - Sale+OE | $66.44 | -21.0K | 20.0K | -51% | -$1.39M |
| D | 2022-04-18 | 2022-04-14 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | M - OptEx | $16.00 | +16.2K | 40.9K | +65% | +$259.0K |
| DMA | 2022-04-13 | 2022-04-01+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.20 | +73.7K | 88.4K | +501% | +$530.4K |
| DM | 2022-04-05 | 2022-04-01+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $17.48 | -104.2K | 42.3K | -71% | -$1.82M |
| DM | 2022-04-05 | 2022-04-01+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $10.90 | +73.7K | 88.4K | +501% | +$803.0K |
| DM | 2022-01-19 | 2022-01-14 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | S - Sale+OE | $65.55 | -21.0K | 26.9K | -44% | -$1.37M |
| D | 2022-01-19 | 2022-01-14 | ARVN | ARVINAS, INC. | Morrison Briggs | Dir | M - OptEx | $16.00 | +16.2K | 45.7K | +55% | +$259.0K |
| D | 2021-12-20 | 2021-12-17 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | CEO, Dir | S - Sale+OE | $20.00 | -35.2K | 48.3K | -42% | -$703.1K |
| D | 2021-12-20 | 2021-12-17 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | CEO, Dir | M - OptEx | $10.90 | +35.2K | 83.5K | +73% | +$383.2K |
| DM | 2021-09-21 | 2021-09-17+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | CEO, Dir | S - Sale+OE | $20.07 | -70.3K | 48.3K | -59% | -$1.41M |
| DM | 2021-09-21 | 2021-09-17+ | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | CEO, Dir | M - OptEx | $7.20 | +70.3K | 118.6K | +146% | +$506.2K |
Purchase Sale Sale after option exercise All abbreviations